What is the appropriate lactulose dosing for a 9‑month‑old infant with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lactulose Dosing for 9-Month-Old with Constipation

For a 9-month-old infant with constipation, start lactulose at 2.5 to 10 mL per day in divided doses, adjusting to produce 2-3 soft stools daily. 1

Specific Dosing Algorithm

Initial dose: Begin with 2.5 mL daily for younger infants (closer to 6 months) or up to 5-7.5 mL daily for infants approaching 12 months, divided into 2 doses 1

Titration strategy:

  • If diarrhea occurs, reduce the dose immediately 1
  • If no response after 2-3 days, increase gradually by 2.5 mL increments
  • Maximum range: up to 10 mL daily in divided doses for this age group 1
  • Goal: 2-3 soft stools per day, not liquid diarrhea

Evidence Quality and Context

The FDA labeling provides the clearest guidance, though it acknowledges "very little information on the use of lactulose in young children" has been recorded 1. The recommended infant dose of 2.5-10 mL daily represents the official guidance despite limited pediatric data.

Alternative consideration: European guidelines suggest lactulose is appropriate and authorized for infants under 6 months 2, 3, with one Dutch guideline specifically recommending lactulose as first-choice treatment for children under 1 year 3. This provides additional support for its use in this age group.

Practical Administration

  • Administer in divided doses (typically twice daily)
  • Can mix with formula, breast milk, or water for easier administration
  • The 15 mL/10g concentration means 2.5 mL = approximately 1.67g lactulose 1
  • Response may take 24-48 hours or longer 1

Critical Safety Considerations

Monitor closely for:

  • Hyponatremia and dehydration - infants receiving lactulose are specifically at risk 1
  • Excessive diarrhea requiring immediate dose reduction 1
  • Adequate fluid intake to prevent dehydration

When to stop immediately:

  • If diarrhea persists despite dose reduction 1
  • Signs of dehydration (decreased urine output, lethargy, sunken fontanelle)
  • Electrolyte disturbances

Comparative Context

Research suggests that when comparing lactulose to lactitol in pediatric constipation, lactulose requires higher doses (500-750 mg/kg/day versus 250-400 mg/kg/day for lactitol) and causes more adverse effects including abdominal pain and flatulence 4, 5. For a 9kg infant, this translates to approximately 4.5-6.75 mL of lactulose daily (at 667 mg/mL concentration), which aligns with the FDA's 2.5-10 mL range.

Duration of Treatment

Continue treatment long-term as needed to maintain regular bowel movements 1. Unlike stimulant laxatives, lactulose can be used for extended periods, though the goal is eventual weaning once normal bowel patterns are established.

References

Research

[Constipation in infants and children: How should it be treated?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016

Research

[Lactitol in chronic idiopathic constipation in children].

La Pediatria medica e chirurgica : Medical and surgical pediatrics, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.